Burning Rock Biotech Ltd
BNR34.000USD
+3.380+11.04%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
306.98M시가총액
손실P/E TTM
자세한 내용은 Burning Rock Biotech Ltd 회사
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Burning Rock Biotech Ltd 정보
종목 코드 BNR
회사 이름Burning Rock Biotech Ltd
상장일Jun 12, 2020
CEOHan (Yusheng)
직원 수674
유형Depository Receipt
회계 연도 종료Jun 12
주소No. 5 Xingdao Ring Road North
도시GUANGZHOU
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가China
우편 번호510005
전화
웹사이트https://www.brbiotech.com/
종목 코드 BNR
상장일Jun 12, 2020
CEOHan (Yusheng)
Burning Rock Biotech Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Ms. Xiaozhi Hu
Ms. Xiaozhi Hu
Senior Director in Finance
Senior Director in Finance
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
수익 분석
FY2019
FY2018
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
China (Mainland)
0.00
0.00%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Wed, Feb 4
마지막 업데이트: Wed, Feb 4
주주
주주 유형
주주
주주
비율
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
기타
57.55%
주주
주주
비율
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
기타
57.55%
주주 유형
주주
비율
Private Equity
20.91%
Hedge Fund
11.37%
Investment Advisor/Hedge Fund
6.30%
Bank and Trust
5.14%
Corporation
3.92%
Investment Advisor
0.85%
Research Firm
0.58%
기타
50.93%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
39
3.80M
46.56%
--
2025Q3
49
4.65M
47.27%
-5.46K
2025Q2
58
4.65M
51.33%
-759.34K
2025Q1
65
5.41M
53.38%
+589.94K
2024Q4
74
5.54M
50.70%
+348.38K
2024Q3
93
5.26M
57.60%
-7.02K
2024Q2
108
5.27M
61.36%
-5.69K
2024Q1
121
5.30M
64.27%
-181.25K
2023Q4
137
5.23M
65.24%
+745.66K
2023Q3
205
5.00M
74.63%
-61.48K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Northern Light Venture Capital
1.05M
11.68%
--
--
Mar 31, 2025
Kynam Capital Management LP
994.88K
11.02%
--
--
Sep 30, 2025
Lyfe Capital
833.84K
9.24%
--
--
Mar 31, 2025
CRCM L.P.
486.43K
5.39%
+264.85K
+119.53%
Dec 16, 2025
China Merchants Bank Co Ltd
462.99K
5.13%
--
--
Mar 31, 2025
Quantum Boundary Holdings Ltd
353.92K
3.92%
+350.62K
+10637.83%
Mar 31, 2025
Amova Asset Management Americas, Inc
45.55K
0.5%
+45.55K
--
Dec 31, 2024
Amova Asset Management Co., Ltd.
34.84K
0.39%
-9.09K
-20.68%
Sep 30, 2025
Renaissance Technologies LLC
31.72K
0.35%
--
--
Sep 30, 2025
BofA Global Research (US)
29.18K
0.32%
-100.00
-0.34%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Avantis Responsible Emerging Markets Equity ETF
0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
0%
Avantis Responsible Emerging Markets Equity ETF
비율0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
비율0%
SPDR S&P Emerging Markets Small Cap ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
날짜
배당락일
유형
비율
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
